To Download a copy of the presentation click here.
To Download a copy of the Q&A Responses click here.
Moderator:
Dana S. Wollins, DrPH, MGC
Senior Vice President, Strategy
Infectious Diseases Society of America
Topics
Clade-1 Mpox: Update & Preparing for Potential Future Spread
Agam Rao, MD, FIDSA
CAPT, U.S. Public Health Service
Medical Officer
Poxvirus and Rabies Branch
U.S. Centers for Disease Control and Prevention
CDC’s New Respiratory Infection Guidance
Brendan Jackson, MD, MPH
Commander, U.S. Public Health Service
Lead, Respiratory Viruses Response
U.S. Centers for Disease Control and Prevention
COVID-19 Antivirals: Closing the Treatment Gap
COVID Epi Update
Pragna Patel, MD, MPH
Chief Medical Officer
Coronavirus and Other Respiratory Viruses Division
National Center for Immunization and Respiratory Diseases
U.S. Centers for Disease Control and Prevention
Real-World Effectiveness of COVID-19 Antivirals: The Latest Data
Therese Tripler, PhD
Scientific Program Manager
National Center for Advancing Translational Sciences
National Institutes of Health
Clinical Considerations
Peter V. Chin-Hong, MD
Professor of Medicine and Associate Dean for Regional Campus
Director, Transplant and Immunocompromised Host Infectious Disease Program
University of California, San Francisco
